Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 4Completed 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 4Nasopharyngeal Carcinoma 3Adenocarcinoma Of Esophagus 3Precancerous Conditions 2Neoplasms 2Colorectal Neoplasms 2Barrett Esophagus 2Thyroid Neoplasms 1Signs and Symptoms 1Rectal Neoplasms 1Peptic Ulcer 1Pathologic Complete Response 1Melanoma 1Intestinal Neoplasms 1Inflammatory Bowel Diseases 1Gastroparesis 1Gastroesophageal Reflux 1Gastric Outlet Obstruction 1Fistula 1Esophageal Squamous Cell Carcinoma 1Esophageal Achalasia 1Colonic Neoplasms 1Celiac Disease 1Anemia, Iron-Deficiency 1

Interventions

Oxaliplatin 47Capecitabine 46Fluorouracil 40Leucovorin 30Radiotherapy 25Irinotecan 20Chemoradiotherapy 14Bevacizumab 14Cetuximab 12Neoadjuvant Therapy 11Folfox protocol 11Chemotherapy, Adjuvant 11Laparoscopy 10XELOX 9Drug Therapy 9Surgical Procedures, Operative 6Robotic Surgical Procedures 5Radiation 5Mastectomy, Segmental 5Surveys and Questionnaires 4Radiotherapy, Intensity-Modulated 4Panitumumab 4Gemcitabine 4durvalumab 3Simvastatin 3Magnetic Resonance Spectroscopy 3Indocyanine Green 3FOLFOXIRI protocol 3tislelizumab 2regorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Rectal Neoplasms × Endoscopy × Clear all
NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡